2030 年图像引导放射治疗市场报告(按细分市场、地域、动态、最新发展和战略见解)

  • Report Code : TIPRE00009118
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

 

[研究报告] 图像引导放射治疗市场规模预计将从 2022 年的 18.1425 亿美元激增至 2030 年的 56.5072 亿美元;预计 2022-2030 年期间市场复合年增长率 15.3%。

 

分析师观点:

在尖端技术进步和个性化癌症治疗日益重要性的推动下,图像引导放射治疗市场有望实现显著增长和转型。图像引导放射治疗利用实时成像精确瞄准肿瘤,在最大限度地减少健康组织的辐射暴露方面发挥着关键作用,从而减少副作用并改善患者预后。通过结合人工智能 (AI) 和机器学习 (ML) 算法,图像引导放射治疗系统变得更加复杂,使肿瘤学家能够以前所未有的精度根据个体患者需求量身定制放射治疗计划。此外,图像引导放射治疗的可及性和可负担性预计将提高,确保更多患者能够从这种革命性的癌症治疗方法中受益,最终提高癌症患者的生存率和生活质量。

 

市场概况:

放射治疗是一种使用电离辐射治疗癌细胞的局部治疗方法。图像引导放射治疗是在放射治疗期间使用周期性二维和三维成像来根据实际放射治疗计划的图像坐标引导放射治疗的方法。图像引导放射治疗可以帮助降低手术的创伤性和精确性,从而缩短住院时间并减少手术次数。图像引导放射治疗是追踪癌症并保护正常组织的最先进技术。该技术是最有效的放射治疗类型之一,可减少对正常组织的辐射剂量、减少副作用并改善治疗效果。

图像引导放射治疗市场的增长受到多种协同因素的推动,包括强大的医疗基础设施、日益增长的癌症患病率、有利的报销政策、技术创新、积极的研究计划、明确的监管框架以及微创手术的日益普及。持续的技术进步、对非侵入性癌症干预措施的更多重视以及支持性医疗生态系统预计将维持这一上升趋势。

 

定制此报告以满足您的需求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

图像引导放射治疗市场:

Image Guided Radiotherapy Market
  • 获取此报告的关键市场趋势。
    这个免费样品将包括数据分析,从市场趋势到估计和预测。

 

市场驱动因素:

 

全球癌症发病率上升推动全球图像引导放射治疗市场

全球卫生系统正在见证癌症患病率的大幅上升。根据世界卫生组织 (WHO) 的数据,2019 年全球约有 960 万人死于癌症。根据同一来源的数据, 男性中最常见的是结直肠癌、肝癌、前列腺癌、肺癌和胃癌,而女性中最常见的是乳腺癌、结直肠癌和宫颈癌。

根据英国癌症研究中心的数据,2020 年,英国每年约有 16 万人死于癌症。根据世界卫生组织的数据,癌症是全球主要死亡原因之一,2020 年约有 1000 万人死于癌症。2020 年最常见的癌症类型是乳腺癌(226 万例)和肺癌(221 万例)。根据美国癌症协会的数据,到 2040 年,全球癌症负担预计将达到约 2840 万例,比 2020 年增加 47%,由于人口结构变化,发展中国家的癌症负担将进一步增加。然而,全球化和经济增长可能会加剧日益增加的风险因素,这进一步加剧了这一问题。全球癌症观察站 (GLOBOCAN) 估计,2020 年全球癌症病例为 1930 万例。GLOBOCAN 预测,到 2040 年,印度的癌症病例将比 2020 年增加到 208 万例,增幅为 57.5%。据世卫组织称,2020 年全球有近 230 万名女性被诊断出患有乳腺癌,约有 68.5 万人死于乳腺癌。据 Advocate Health Care 称,超过 60% 的癌症患者在治疗过程中会接受某种形式的放射治疗。这是因为放射疗法在对抗多种癌症方面非常有效,因为它可以破坏癌细胞的繁殖能力。图像引导放射治疗使放射治疗师能够更好地定位目标区域,并在治疗前或治疗期间将放射束对准肿瘤。因此,癌症的高发病率预计将推动图像引导放射治疗的采用。

根据世界卫生组织 2021 年 3 月发布的数据,超过 50% 的癌症患者将放射治疗作为癌症管理和护理的一部分。此外,根据同一数据,放射治疗主要用于治疗最常见的癌症类型,例如结直肠癌、肺癌、乳腺癌和宫颈癌。从患者的角度来看,早期发现和诊断可以避免不必要的疼痛和痛苦。它还可以减少治疗的规模和成本。此外,政府的认识将推动市场的发展。例如,英国公共卫生部与卫生部和英国国民医疗服务体系合作,领导了“明确癌症”计划。该计划旨在通过提高公众对癌症体征和症状的认识并进一步敦促人们立即就医来改善癌症的早期诊断。

 

节段分析:

根据类型,图像引导放射治疗市场细分为产品和服务。产品细分市场在 2022 年占据了最大的市场份额。服务细分市场预计在 2022-2030 年期间的复合年增长率最高,为 15.5%。人们对放射治疗的认识不断提高,增加了对直线加速器 (LINAC) 和 MRI-LINAC 等放射治疗设备的需求,这些设备有助于为大量患者提供治疗。此外,肿瘤中心的数量大幅增长,进一步产生了对放射治疗设备的需求,进而推动了产品细分市场的发展,并促进了图像引导放射治疗市场的增长。

根据应用,图像引导放射治疗市场细分为乳腺癌、肺癌、胃肠癌、前列腺癌、妇科癌症、头颈癌等。乳腺癌领域在 2022 年占据最大的市场份额。预计肺癌领域在 2022-2030 年期间的复合年增长率最高,为 16.3%。

根据成像类型,图像引导放射治疗市场细分为磁共振成像 (MRI)、正电子发射断层扫描 (PET)、计算机断层扫描 (CT) 成像等。磁共振成像 (MRI) 部分在 2022 年占据最大的市场份额。预计计算机断层扫描 (CT) 成像部分在 2022 年至 2030 年期间的复合年增长率最高,为 15.8%。

根据最终用户,图像引导放射治疗市场分为医院、肿瘤中心和放射治疗中心。医院部分在 2022 年占据最大的市场份额。预计肿瘤中心部分在 2022-2030 年期间的复合年增长率最高,为 16.0%。

 

区域分析:

北美在图像引导放射治疗市场中占据主导地位。2022 年,北美图像引导放射治疗市场价值为 7.607 亿美元,预计到 2030 年将达到 24.0912 亿美元;预计 2022-2030 年期间的复合年增长率为 15.5%。北美图像引导放射治疗市场分为美国、加拿大和墨西哥。北美拥有先进的医疗基础设施,这是由于癌症发病率较高。在北美,先进的医疗基础设施加上易于获取的先进医疗技术,为先进治疗方式(如图像引导放射治疗)的整合创造了有利的环境。该地区特别全面的医疗保健报销框架正在增加包括图像引导放射治疗在内的先进治疗的采用,确保更广泛的患者能够获得这些治疗。这些因素的汇合为扩大和加强图像引导放射治疗市场提供了动力。

由于拥有先进的治疗设施、合格的医疗专业人员以及政府对研发的支持,预计欧洲图像引导放射治疗市场将在预测期内大幅增长。由于癌症患病率不断上升、癌症意识不断增强以及新疗法的出现,亚太地区是增长最快的市场。

 

 

图像引导放射治疗市场区域洞察

Insight Partners 的分析师已详细解释了预测期内影响图像引导放射治疗市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的图像引导放射治疗市场细分和地理位置。

Image Guided Radiotherapy Market
  • 获取图像引导放射治疗市场的区域特定数据

图像引导放射治疗市场报告范围

报告属性细节
2022 年市场规模18.1425亿美元
2030 年的市场规模56.5072亿美元
全球复合年增长率(2022 - 2030 年)15.3%
史料2020-2022
预测期2022-2030
涵盖的领域按类型
  • 產品與服務
按应用
  • 乳腺癌
  • 肺癌
  • 胃肠道癌症
  • 前列腺癌
  • 妇科癌症
  • 头颈癌
按成像类型
  • 磁共振成像
  • 正电子发射断层扫描
  • 计算机断层扫描成像
按最终用户
  • 医院
  • 肿瘤中心
  • 放射治疗中心
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 维特雷
  • 通用电气医疗
  • 日立制作所有限公司
  • 西门子股份公司
  • 荷兰皇家飞利浦公司
  • 东芝公司
  • 瓦里安医疗系统公司
  • Vision RT 有限公司
  • 医科达公司

 

图像引导放射治疗市场参与者密度:了解其对业务动态的影响

图像引导放射治疗市场正在快速增长,这得益于终端用户需求的不断增长,这些需求源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者需求,并利用新兴趋势,从而进一步推动市场增长。

市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。

在图像引导放射治疗市场运营的主要公司有:

  1. 维特雷
  2. 通用电气医疗
  3. 日立制作所有限公司
  4. 西门子股份公司
  5. 荷兰皇家飞利浦公司

免责声明上面列出的公司没有按照任何特定顺序排列。


Image Guided Radiotherapy Market

 

  • 了解图像引导放射治疗市场主要参与者概况

 

关键球员分析:

ViewRay、GE Healthcare、日立有限公司;西门子股份公司、荷兰皇家飞利浦电子公司;东芝公司、瓦里安医疗系统公司;Vision RT Ltd.;Elekta AB、Accuray Incorporated 和 HORIBA Group 是图像引导放射治疗市场研究期间分析的关键参与者。

 

最新动态: 

在图像引导放射治疗市场运营的公司高度采用无机和有机战略,例如合并和收购。以下列出了一些最近的市场发展:

  • 2023 年 5 月,飞利浦通过 Zenition 10 扩展了其移动 C 臂产品组合。
  • 2023 年 4 月,GE HealthCare 推出 Pixxoscan,扩大了其磁共振成像 (MRI) 造影剂产品组合。它为客户提供两种领先的大环分子:Clariscan(钆特酸)和 Pixxoscan(钆布醇)。
  • 2023 年 6 月,GE HealthCare 宣布计划通过 AIR 技术扩展其 PET/MR 功能,以提高诊断精度并简化治疗评估,同时提高患者的舒适度。
  • 2022年9月,中国监管机构国家药品监督管理局(NMPA)批准ViewRay的MRIdian磁共振引导放射治疗系统的销售和使用。
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the driving factors for the image guided radiotherapy market?

The factors driving the growth of the image guided radiotherapy market include the rising prevalence of cancer worldwide and the introduction of technologically advanced systems.

Who are the major players in the image guided radiotherapy market?

The image guided radiotherapy market majorly consists of the players such as ViewRay, GE Healthcare, Hitachi, Ltd.; Siemens AG, Koninklijke Philips N.V.; TOSHIBA CORPORATION, Varian Medical Systems, Inc.; Vision RT Ltd.; Elekta AB, Accuray Incorporated, and HORIBA Group.

What is image guided radiotherapy?

Radiation therapy is a local treatment used to treat cancer cells with ionizing radiation. Image-guided radiation therapy is the method of using periodic two- and three-dimensional imaging during radiation treatment to guide radiation therapy based on the image coordinates of the actual radiation treatment plan. Image-guided radiation therapy can help make surgeries less invasive and precise, resulting in shorter hospital stays and fewer procedures. Image-guided radiation therapy is the most advanced technology for tracking cancer and sparing normal tissue. The technology is one of the most efficient types of radiation therapy, reducing the radiation dose to normal tissue, reducing side effects, and improving outcomes.

Which segment is dominating the image guided radiotherapy market?

The global image guided radiotherapy market, based on therapy type is segmented product and services. The product segment held the largest market share in 2022. The proton beam therapy segment is anticipated to register the highest CAGR of 15.5% during 2022–2030. Based on application, the image guided radiotherapy market is segmented into breast cancer, lung cancer, gastrointestinal cancer, prostate cancer, gynecological cancers, head and neck cancer, and others. The breast cancer segment held the largest market share in 2022. The lung cancer segment is anticipated to register the highest CAGR of 16.3% during 2022–2030. Based on imaging type, the image guided radiotherapy market is segmented into magnetic resonance imaging (MRI), positron emission tomography (PET), computed tomography (CT) imaging, and others. The magnetic resonance imaging (MRI) segment held the largest market share in 2022. The computed tomography (CT) imaging segment is anticipated to register the highest CAGR of 15.8% from 2022 to 2030. The image guided radiotherapy market, based on end user is segmented into hospitals, oncology centers, and radiotherapy centers. The hospitals segment held the largest market share in 2022. The oncology centers segment is anticipated to register the highest CAGR of 16.0% during 2022–2030.

What are the growth estimates for the image guided radiotherapy market till 2030?

The image guided radiotherapy market is expected to be valued at US$ 5,650.72million in 2030.

What was the estimated image guided radiotherapy market size in 2022?

The image guided radiotherapy market was valued at US$ 1,814.25 million in 2022.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies - Image Guided Radiotherapy Market

  1. ViewRay
  2. GE Healthcare
  3. Hitachi, Ltd.
  4. Siemens AG
  5. Koninklijke Philips N.V.
  6. TOSHIBA CORPORATION
  7. Varian Medical Systems, Inc.
  8. Vision RT Ltd.
  9. Elekta AB
  10. Accuray Incorporated
  11. HORIBA Group

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.